acetylcarnitine has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 2 studies
Acetylcarnitine: An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, S | 1 |
| Mishra, A | 1 |
| Mishra, SK | 1 |
| Shukla, S | 1 |
| Burks, S | 1 |
| Raymick, J | 1 |
| Robinson, B | 1 |
| Hanig, J | 1 |
| Sarkar, S | 1 |
2 other studies available for acetylcarnitine and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
ALCAR promote adult hippocampal neurogenesis by regulating cell-survival and cell death-related signals in rat model of Parkinson's disease like-phenotypes.
Topics: Acetylcarnitine; Animals; Cell Death; Cell Survival; Hippocampus; Male; Neurogenesis; Nootropic Agen | 2017 |
Neuroprotective effects of acetyl-l-carnitine (ALC) in a chronic MPTP-induced Parkinson's disease mouse model: Endothelial and microglial effects.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylcarnitine; Animals; Astrocytes; Dopamine Plasma | 2019 |